Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV

Journal of Virology

Volumn 75, Issue 3, 2001, Pages 1229-1235

  Wong, D K H ^a   Dudley, D D ^a   Dohrenwend, P B ^a   Lauer, G M ^a   Chung, R T ^a   Thomas, D L ^a   Walker, B D ^a  

^a Partners AIDS Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; POLYPROTEIN; VIRUS PROTEIN;

ARTICLE; B LYMPHOBLAST; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RISK; LIVER BIOPSY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS; VIRUS DETECTION;

BIOPSY; EPITOPES, T-LYMPHOCYTE; HEPACIVIRUS; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; LIVER; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0035148471     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.3.1229-1235.2001     Document Type: Article

References (40)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
2. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
3. Induction in vitro of a primary human antiviral cytotoxic T cell response
4. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
5. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
6. Analysis of a successful immune response against hepatitis C virus
7. Expression and identification of hepatitis C virus polyprotein cleavage products
8. + T cells with viral clearance in acute hepatitis C
9. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
10. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
11. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers
12. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis
13. Genomic structure of the human prototype strata H of hepatitis C virus: Comparison with American and Japanese isolates
14. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
15. Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein
16. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein
17. HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleoprotein residues 81-100 in patients with chronic hepatitis C
18. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes
19. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope protein of HCV
20. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: Identification of multiple epitopes and characterization of patterns of cytokine release
21. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
22. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses seronegative persons
23. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region
24. Analysis of successful immune responses in persons infected with hepatitis C virus
25. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes
26. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
27. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
28. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chrome hepatitis C virus infection
29. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lyrnphoma in allogeneic transplant recipients
30. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
31. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
32. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans
33. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
34. Correlates of hepatitis C virus infections among injection drug users
35. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
36. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants
37. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
38. High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong
39. Liver-derived CTL in hepatitis C virus infection: Breadth and specificity of responses in a cohort of persons with chronic infection
40. CD8+ cells in human immunodeficiency virus type 1 pathogenesis: Cytolytic and noncytolytic inhibition of viral replication